Nissay Asset Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.17M	Sell	5,340 -155	-3%	-$77.2K	0.02%	408
2025 Q4	$2.68M	Buy	5,495 +15	+0.3%	+$6.99K	0.01%	441
2025 Q3	$2.3M	Buy	5,480 +37	+0.7%	+$12.4K	0.01%	470
2025 Q2	$1.56M	Buy	5,443 +208	+4%	+$62.2K	0.01%	555
2025 Q1	$1.61M	Buy	5,235 +43	+0.8%	+$14.7K	0.01%	557
2024 Q4	$1.87M	Buy	5,192 +61	+1%	+$22.4K	0.01%	539
2024 Q3	$1.84M	Sell	5,131 -149	-3%	-$50.3K	0.01%	549
2024 Q2	$1.68M	Sell	5,280 -122	-2%	-$32.3K	0.01%	540
2024 Q1	$1.24M	Buy	5,402 +90	+2%	+$20.3K	0.01%	606
2023 Q4	$1.17M	Buy	5,312 +218	+4%	+$50.2K	0.01%	591
2023 Q3	$1.15M	Buy	5,094 +219	+4%	+$50.4K	0.01%	581
2023 Q2	$1.08M	Buy	4,875 +213	+5%	+$47.2K	0.01%	593
2023 Q1	$1.04M	Buy	+4,662	New	+$1.15M	0.01%	598
2019 Q2	–	Sell	-5,029	Closed	-$590K	–	752
2019 Q1	$590K	Buy	5,029 +144	+3%	+$16.8K	0.02%	613
2018 Q4	$532K	Sell	4,885 -70	-1%	-$8.12K	0.02%	593
2018 Q3	$634K	Buy	4,955 +130	+3%	+$16.1K	0.02%	595
2018 Q2	$546K	Buy	4,825 +128	+3%	+$14.1K	0.02%	620
2018 Q1	$528K	Buy	4,697 +131	+3%	+$16.6K	0.02%	615
2017 Q4	$676K	Buy	+4,566	New	+$580K	0.02%	565